COMPASS Pathways
Nasdaq CMPS · Chesire, United Kingdom
Works in Psychiatry
COMPASS Pathways is a clinical trial sponsor based in Chesire, United Kingdom, listed as Nasdaq CMPS. It has 3 active clinical trials with 974 planned participants, in Psychiatry. Since 2021 it has completed 6 trials and stopped 0 early.
Trial track record · since 2021
Financials · Nasdaq CMPS
Fundraising
Pipeline · 3 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about COMPASS Pathways
COMPASS Pathways is lead sponsor of 3 active clinical trials on ClinicalTrials.gov, with 974 planned participants, in Psychiatry. Since 2021 it has completed 6 trials and stopped 0 early.
COMPASS Pathways is based in Chesire, United Kingdom and is listed as Nasdaq CMPS. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with COMPASS Pathways; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-06.
Approve Suite is not affiliated with COMPASS Pathways. Informational only.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.